Leading players in the clinical microbiology market include bioMerieux S.A. (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.).
Seattle, WA -- (SBWIRE) -- 11/11/2016 -- The report "Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Browse 74 market data tables with 62 figures spread through 176 pages and in-depth TOC on "Microbiology Testing/Clinical Microbiology Market"
Early buyers will receive 10% customization on this report.
The Global Clinical Microbiology Market Is Projected to reach USD 5.77 Billion by 2021 From USD 3.35 Billion in 2016, at a CAGR of 11.5%, during 2016 to 2021
On the basis of product, the clinical microbiology market is categorized into instruments [laboratory instruments (incubators, gram strainers, bacterial colony counters, autoclave sterilizers, microbial air samplers, anaerobic culture systems, petridish fillers, blood culture systems, microbial culture systems, and other laboratory instruments) and microbiology analyzers (molecular diagnostic instruments, microscopes, and mass spectrometers)] and reagents (pathogen specific kits and general reagents).
Ask For Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=219135367
The instruments segment is expected to account for the larger share of the global clinical microbiology market in 2016. However, reagents segment is projected to grow faster than the instruments segment, growing at a double-digit CAGR during 2016–2021. Growth in the reagents segment is mainly driven by growing trend of reagent rental agreements (along with instrument sales) by prominent reagent manufacturers, rising private-public funding for researches on specific infectious diseases, increasing market availability of pathogen-specific kits across the globe, and growing demand for specific clinical microbiology reagents during epidemic outbreaks.
Technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches are the key market drivers for the clinical microbiology industry.
Get Sample Copy@ http://www.marketsandmarkets.com/requestsample.asp?id=219135367
Furthermore, improving healthcare infrastructure across the emerging markets and growing market demand for advanced molecular diagnostic products provide opportunities for players in the clinical microbiology market. Operational barriers for diagnostic test usage and bundled sales by market giants across major markets are the major challenge limiting the growth of the global clinical microbiology market.
In 2016, North America and Europe are expected to be the mature markets for clinical microbiology products. However, emerging regions such as Asia-Pacific (including Japan, China, and India) are expected to become the new revenue-generating pockets in the clinical microbiology market in the next five years. The North American clinical microbiology market is expected to hold the largest share of the global clinical microbiology market in 2016.
However, Asia-Pacific clinical microbiology market is projected to grow at the highest CAGR during the forecast period owing to the growing number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and rising incidences of infectious diseases.
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Knowledgestore.asp
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 888-600-6441